NCT07038837View on ClinicalTrials.gov

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

70,000

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2028

Conditions

Malaria InfectionMalaria Vaccines

Interventions

OTHER

"Synchronised arm (intervention)"

Vaccines received together with CPS

Trial Locations (1)

Unknown

Medecin sans Frontières, Moïssala

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Epicentre, Paris, France.

UNKNOWN

collaborator

Chad Ministry of Public Health Expanded Programme on Immunisation (EPI)

UNKNOWN

collaborator

Chad Ministry of Public Health National Malaria Control Programme (NMCP)

UNKNOWN

collaborator

Liverpool School of Tropical Medicine

OTHER

lead

Epicentre

OTHER

NCT07038837 - Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad | Biotech Hunter | Biotech Hunter